礼来第二季度营收155.6亿美元,口服减重药临床数据未达预期

环球网
Aug 08

【环球网财经综合报道】当地时间8月7日,美国制药企业礼来公司发布了2025年第二季度财报。财报显示,第二季度,礼来实现营收达155.6亿美元,超出华尔街预期的146.9亿美元;净利润为56.6亿美元,合每股6.29美元,而去年同期为29.7亿美元,合每股3.28美元。此外,剔除一次性无形资产相关项目后,公司调整后每股收益为6.31美元,超出市场预期的5.57美元。东方IC进一步来讲,礼来旗下两款...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10